首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Using Polypeptide Bearing Furan Side Chains as a General Platform to Achieve Highly Effective Preparation of Smart Glycopolypeptide Analogue-Based Nano-Prodrugs for Cancer Treatment
【24h】

Using Polypeptide Bearing Furan Side Chains as a General Platform to Achieve Highly Effective Preparation of Smart Glycopolypeptide Analogue-Based Nano-Prodrugs for Cancer Treatment

机译:使用毛叶侧链的多肽作为一般平台,实现高效制备癌症治疗的智能甘油肽类纳米前药

获取原文
获取原文并翻译 | 示例
           

摘要

Although several synthetic polypeptide-based nano-prodrugs (NPDs) have entered clinical trials for cancer treatment, achieving a highly effective production of the NPDs for clinical translation remains a challenge. Herein, we develop a typical preparation of pH/glutathione (GSH) dual-responsive glycopolypeptide analogue NPDs having a high drug capsulation/loading efficiency of ca. 93% and ca. 27% even based on ring-opening polymerization (ROP) of a novel and general furan-containing N-carboxyanhydride (NCA) monomer, which facilitates the Diels-Alder (D-A) side-chain functionalization by maleimide modified chemotherapy drug without using any reactive additives. High reactivity of the D-A reaction resulting in the high preparation efficiency of the NPDs is confirmed by H-1 NMR and density functional theory (DFT) calculations. The self-assembled properties as well as the dual-responsiveness of the NPDs are systemically studied by particle size and zeta potential assay, transmission electron microscopy and drug-delivery dynamics. The cell uptake mechanism, intracellular drug distribution, in vitro/vivo antitumor activity evaluations and the main organ damages of the NPDs are all investigated. Our work can provide a good solution to solve the inefficient fabrication of the smart synthetic polypeptide-based micelles for cancer treatment by following this general and sophisticated platform.
机译:虽然几种基于合成的基于多肽的纳米前药(NPDS)进入癌症治疗的临床试验,但实现了对临床翻译的高效生产的高效生产仍然是一个挑战。在此,我们开发了具有高药物填充/加载效率的pH /谷胱甘肽(GSH)双响应型糖基肽类似物NPD的典型制备。 93%和CA.甚至基于新的含有新型呋喃的N-羧酸酐(NCA)单体的开环聚合(ROP)甚至基于含有一般呋喃的聚合(ROP),这促进了马来酰亚胺改性化疗药物的Diels-Alder(Da)侧链官能化而不使用任何反应性添加剂。通过H-1 NMR和密度泛函理论(DFT)计算证实了D-A反应的高反应性导致NPDS的高制量效率和NPDS的效率。通过粒度和Zeta电位测定,透射电子显微镜和药物输送动力学来系统地研究了自组装的性质以及NPD的双响应性。全部研究了细胞摄取机制,细胞内药物分布,体外/体内抗肿瘤活性评估和NPDS的主要器官损伤。我们的工作可以提供良好的解决方案,以解决智能合成多肽的胶束对癌症治疗的效率低下的制造,以后通过遵循该一般和复杂的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号